Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02420635
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
BC3 | 2-amino-7-(pyridin-3-ylmethyl)- 3,5-dihydro-4H-pyrrolo[3,2-d]pyrimidin- 4-one | A,B,C | 3DJF | 0.71 | |
24X | H,L | 2EC9 | 0.76 | ||
B14 | 1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'- DIFLUOROSPIRO[PIPERIDINE-4,2'(1'H)- QUINAZOLINE]-4'-AMINE | A,B | 3E7T | 0.71 | |
L1C | (2R,4S)-N^1^-(4-chlorophenyl)-4- (2,4-difluorophenyl)-4-hydroxy- N^2^-(2-oxo-2H-1,3'-bipyridin-6'- yl)pyrrolidine-1,2-dicarboxamide | A | 2W3I | 0.73 | |
C24 | 3-({2-[(4-CARBAMIMIDOYL-PHENYLAMINO)- METHYL]-3-METHYL-3H-BENZOIMIDAZOLE- 5-CARBONYL}-PYRIDIN-2-YL-AMINO)- PROPIONIC ACID ETHYL ESTER | B,C | 1KTS | 0.73 | |
NIX | NALIDIXIC ACID | A,B | 2BQ2 | 0.76 | |
4RB | 4-(6-{[(1R)-1-(hydroxymethyl)propyl]amino}imidazo[1,2- b]pyridazin-3-yl)benzoic acid | A | 3BQR | 0.71 | |
NA4 | 4-[5-(2-CARBOXY-1-FORMYL-ETHYLCARBAMOYL)- PYRIDIN-3-YL]-BENZOIC ACID | A,C | 1RHM | 0.73 | |
CEI | N-[3-BENZYL-5-(4-HYDROXYPHENYL)PYRAZIN- 2-YL]-2-(4-HYDROXYPHENYL)ACETAMIDE | A,B | 2PSJ | 0.74 | |
CEI | N-[3-BENZYL-5-(4-HYDROXYPHENYL)PYRAZIN- 2-YL]-2-(4-HYDROXYPHENYL)ACETAMIDE | A | 2F8P | 0.74 | |
CEI | N-[3-BENZYL-5-(4-HYDROXYPHENYL)PYRAZIN- 2-YL]-2-(4-HYDROXYPHENYL)ACETAMIDE | A | 1S36 | 0.74 | |
S91 | [4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN- 2-YL}AMINO)PHENYL]ACETIC ACID | A | 2Z8C | 0.75 | |
S91 | [4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN- 2-YL}AMINO)PHENYL]ACETIC ACID | A | 2Z7L | 0.75 | |
COP | N-(4-CARBOXY-4-{4-[(2,4-DIAMINO- PTERIDIN-6-YLMETHYL)-AMINO]-BENZOYLAMINO}- BUTYL)-PHTHALAMIC ACID | A | 1OHJ | 0.79 | |
COP | N-(4-CARBOXY-4-{4-[(2,4-DIAMINO- PTERIDIN-6-YLMETHYL)-AMINO]-BENZOYLAMINO}- BUTYL)-PHTHALAMIC ACID | A | 1OHK | 0.79 | |
DVP | METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN- 6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE- 4-CARBOXYLATE | A,B,C,D,E,F, G,H | 3H4V | 0.73 | |
AGN | A | 1GNP | 0.73 | ||
985 | (2E)-3-{3-[6-(4-methyl-1,4-diazepan- 1-yl)pyrazin-2-yl]phenyl}prop-2- enoic acid | A | 3F2A | 0.7 | |
PD8 | PHOSPHORYLATED DIHYDROPTEROATE | A | 1W78 | 0.92 | |
DZF | 5-DEAZAFOLIC ACID | A,B | 2DHF | 0.8 | |
DZF | 5-DEAZAFOLIC ACID | A,B | 1DYH | 0.8 | |
DZF | 5-DEAZAFOLIC ACID | A,B,C,D | 1CDE | 0.8 | |
3BI | (2S)-2-{[(R)-[(3R)-3-carboxy-3- {[(4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}phenyl)carbonyl]amino}propyl](hydroxy)phosphoryl]methyl}pentanedioic acid | A | 3BI1 | 0.73 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 1S1X | 0.71 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 1LWE | 0.71 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 1LW0 | 0.71 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 2HND | 0.71 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 1FKP | 0.71 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 1S1U | 0.71 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 1LWF | 0.71 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 2HNY | 0.71 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 1VRT | 0.71 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 1LWC | 0.71 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 1JLB | 0.71 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 3HVT | 0.71 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 1JLF | 0.71 | |
THH | N-[4-({[(6S)-2-AMINO-4-HYDROXY- 5-METHYL-5,6,7,8-TETRAHYDROPTERIDIN- 6-YL]METHYL}AMINO)BENZOYL]-L-GLUTAMIC ACID | A,B | 3DCJ | 0.71 | |
THH | N-[4-({[(6S)-2-AMINO-4-HYDROXY- 5-METHYL-5,6,7,8-TETRAHYDROPTERIDIN- 6-YL]METHYL}AMINO)BENZOYL]-L-GLUTAMIC ACID | A,B | 1WSV | 0.71 | |
NTM | QUINOLINIC ACID | A | 3C2O | 0.71 | |
NTM | QUINOLINIC ACID | A,B | 1QAP | 0.71 | |
NTM | QUINOLINIC ACID | A,B,C,D,E,F | 1QPQ | 0.71 | |
NTM | QUINOLINIC ACID | A,B,C | 2B7N | 0.71 | |
ONM | 3'-O-(N-METHYLANTHRANILOYL)-GUANOSINE- 5'-TRIPHOSPHATE | A,C | 1TL7 | 0.72 | |
ONM | 3'-O-(N-METHYLANTHRANILOYL)-GUANOSINE- 5'-TRIPHOSPHATE | A,C | 1U0H | 0.72 | |
PT1 | PTEROIC ACID | A,B | 1TX0 | 0.77 | |
PT1 | PTEROIC ACID | A | 1BR6 | 0.77 | |
PT1 | PTEROIC ACID | A,B | 1HWP | 0.77 | |
OPN | {(2-AMINO-ETHYL)-[2-(2-OXO-1,2- DIHYDRO-[1,8]NAPHTHYRIDIN-3-YL)- ACETYL]-AMINO}-ACETIC ACID | A,B,C,D | 1HZS | 0.72 | |
FE1 | METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN- 6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE- 4-CARBOXYLATE | A,B,C,D | 2QHX | 0.74 | |
THF | 5-HYDROXYMETHYLENE-6-HYDROFOLIC ACID | A,B,C,D | 1EJI | 0.7 | |
THF | 5-HYDROXYMETHYLENE-6-HYDROFOLIC ACID | A | 1U3G | 0.7 | |
THF | 5-HYDROXYMETHYLENE-6-HYDROFOLIC ACID | A | 2TDD | 0.7 | |
FFO | 5-FORMYL-6-HYDROFOLIC ACID | A,B,C,D | 1EQB | 0.71 | |
FFO | 5-FORMYL-6-HYDROFOLIC ACID | A | 1JOM | 0.71 | |
FFO | 5-FORMYL-6-HYDROFOLIC ACID | A | 1PJ7 | 0.71 | |
FFO | 5-FORMYL-6-HYDROFOLIC ACID | A,B,C,D | 1DFO | 0.71 | |
FFO | 5-FORMYL-6-HYDROFOLIC ACID | A,B | 2VMY | 0.71 | |
FFO | 5-FORMYL-6-HYDROFOLIC ACID | A,B | 1JOL | 0.71 | |
FFO | 5-FORMYL-6-HYDROFOLIC ACID | A | 1WOP | 0.71 | |
4QB | 3-{2-ETHYL-6-[4-(QUINOXALIN-2-YLAMINO)- BENZOYLAMINO]-HEXANOYLAMINO}-4- OXO-BUTYRIC ACID | A | 1RWN | 0.79 | |
MTX | METHOTREXATE | A,B | 1DRB | 0.76 | |
MTX | METHOTREXATE | A,B,C,D | 2C7V | 0.76 | |
MTX | METHOTREXATE | A | 1U70 | 0.76 | |
MTX | METHOTREXATE | A,B,C,D | 1MXF | 0.76 | |
MTX | METHOTREXATE | A | 2QK8 | 0.76 | |
MTX | METHOTREXATE | A,B | 1RB3 | 0.76 | |
MTX | METHOTREXATE | A,B | 1DHJ | 0.76 | |
MTX | METHOTREXATE | A | 3DAU | 0.76 | |
MTX | METHOTREXATE | A | 1U72 | 0.76 | |
MTX | METHOTREXATE | A,B | 2DRC | 0.76 | |
MTX | METHOTREXATE | A,B | 1D1G | 0.76 | |
MTX | METHOTREXATE | A,B | 1DDR | 0.76 | |
MTX | METHOTREXATE | A,B | 1E7W | 0.76 | |
MTX | METHOTREXATE | A | 1RX3 | 0.76 | |
MTX | METHOTREXATE | A | 3DFR | 0.76 | |
MTX | METHOTREXATE | A,B,C,D | 1P33 | 0.76 | |
MTX | METHOTREXATE | A | 3DAT | 0.76 | |
MTX | METHOTREXATE | A,B | 1DHI | 0.76 | |
MTX | METHOTREXATE | A,B | 1TDR | 0.76 | |
MTX | METHOTREXATE | A,B | 1DRA | 0.76 | |
MTX | METHOTREXATE | A | 3EIG | 0.76 | |
MTX | METHOTREXATE | A | 3CD2 | 0.76 | |
MTX | METHOTREXATE | A | 1AO8 | 0.76 | |
MTX | METHOTREXATE | A | 1DF7 | 0.76 | |
MTX | METHOTREXATE | A | 1DLS | 0.76 | |
MTX | METHOTREXATE | A | 1RG7 | 0.76 | |
MTX | METHOTREXATE | A | 1RH3 | 0.76 | |
MTX | METHOTREXATE | A,B | 4DFR | 0.76 | |
MTX | METHOTREXATE | A | 1RA3 | 0.76 | |
MTX | METHOTREXATE | A,B | 1DDS | 0.76 | |
MTX | METHOTREXATE | A | 1DRE | 0.76 | |
MTX | METHOTREXATE | A,B | 1AXW | 0.76 | |
MTX | METHOTREXATE | A | 3CL9 | 0.76 | |
MTX | METHOTREXATE | A,B | 3DRC | 0.76 | |
MTX | METHOTREXATE | A,B,C,D,E | 2OIP | 0.76 | |
AKP | N-(PYRAZIN-2-YLCARBONYL)LEUCYLISOLEUCYL- N~1~-{1-[2-({1-CARBOXY-2-[4-(PHOSPHONOOXY)PHENYL]ETHYL}AMINO)- 1,1-DIHYDROXY-2-OXOETHYL]BUT-3- ENYL}-3-CYCLOHEXYLALANINAMIDE | A,B | 1RGQ | 0.7 | |
OAI | 6-(OXALYL-AMINO)-1H-INDOLE-5-CARBOXYLIC ACID | A | 1C83 | 0.71 | |
LG2 | 6-[1-(3,5,5,8,8-PENTAMETHYL-5,6,7,8- TETRAHYDRONAPHTHALEN-2-YL)CYCLOPROPYL]PYRIDINE- 3-CARBOXYLIC ACID | A,B,C,D | 1H9U | 0.71 | |
MT1 | N-(4-{[(2,4-DIAMINOPTERIDIN-1-IUM- 6-YL)METHYL](METHYL)AMINO}BENZOYL)- L-GLUTAMIC ACID | A,B | 2INQ | 0.74 | |
FOL | FOLIC ACID | A | 1PJ6 | 0.86 | |
FOL | FOLIC ACID | A,B | 1RD7 | 0.86 | |
FOL | FOLIC ACID | A,B | 1DHF | 0.86 | |
FOL | FOLIC ACID | A,B,C,D,E | 1QZF | 0.86 | |
FOL | FOLIC ACID | A | 4CD2 | 0.86 | |
FOL | FOLIC ACID | A | 1RX7 | 0.86 | |
FOL | FOLIC ACID | A | 1RX2 | 0.86 | |
FOL | FOLIC ACID | A | 1RX8 | 0.86 | |
FOL | FOLIC ACID | A | 1RA2 | 0.86 | |
FOL | FOLIC ACID | A,B | 1RE7 | 0.86 | |
FOL | FOLIC ACID | A | 7DFR | 0.86 | |
FOL | FOLIC ACID | A | 1VIF | 0.86 | |
FOL | FOLIC ACID | A,B | 1RB2 | 0.86 | |
FOL | FOLIC ACID | A | 1CD2 | 0.86 | |
FOL | FOLIC ACID | A | 2CD2 | 0.86 | |
FOL | FOLIC ACID | A,B | 1DYI | 0.86 | |
FOL | FOLIC ACID | A | 1DRF | 0.86 | |
FOL | FOLIC ACID | A,B,C,D | 3BMC | 0.86 | |
FOL | FOLIC ACID | A,B | 2D0K | 0.86 | |
FOL | FOLIC ACID | A | 1RA8 | 0.86 | |
P16 | 6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)PHENYL]AMINO}- 8-METHYLPYRIDO[2,3-D]PYRIMIDIN- 7(8H)-ONE | A | 2FO0 | 0.73 | |
P16 | 6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)PHENYL]AMINO}- 8-METHYLPYRIDO[2,3-D]PYRIMIDIN- 7(8H)-ONE | A | 1OPK | 0.73 | |
P16 | 6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)PHENYL]AMINO}- 8-METHYLPYRIDO[2,3-D]PYRIMIDIN- 7(8H)-ONE | A,B | 1OPL | 0.73 | |
P16 | 6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)PHENYL]AMINO}- 8-METHYLPYRIDO[2,3-D]PYRIMIDIN- 7(8H)-ONE | A,B | 2G2H | 0.73 | |
1IQ | 2-(4-ISOPROPYL-4-METHYL-5-OXO-4,5- DIHYDRO-1H-IMIDAZOL-2-YL)QUINOLINE- 3-CARBOXYLIC ACID | A | 1Z8N | 0.73 | |
Q2Y | 4-OXO-3-[2-(5-{[4-(QUINOXALIN-2- YLAMINO)-BENZOYLAMINO]-METHYL}- THIOPHEN-2-YL)-ACETYLAMINO]-PENTANOIC ACID | A | 1RWM | 0.72 | |
IQA | (5-OXO-5,6-DIHYDRO-INDOLO[1,2-A]QUINAZOLIN- 7-YL)-ACETIC ACID | A | 1OM1 | 0.72 | |
AXD | 2-[4-({2-[(2S,5R)-2-(AMINOMETHYL)- 5-ETHYNYLPYRROLIDIN-1-YL]-2-OXOETHYL}AMINO)- 4-METHYLPIPERIDIN-1-YL]ISONICOTINIC ACID | B | 2I03 | 0.73 | |
859 | 2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN- 4-YL}AMINO)BENZAMIDE | A,B | 2NO3 | 0.75 | |
MS1 | A,B | 1OZ0 | 0.73 | ||
TGF | 2-[4-(4-{4-[(2-AMINO-5-FORMYL-4- OXO-3,4,5,6,7,8-HEXAHYDRO-PTERIDIN- 6-YLMETHYL)-AMINO]-BENZOYLAMINO}- 4-CARBOXY-BUTYRYLAMINO)-4-CARBOXY- BUTYRYLAMINO]-PENTANEDIOIC ACID | A,B,C,D | 1LS3 | 0.71 | |
3IN | N-[2(S)-CYCLOPENTYL-1(R)-HYDROXY- 3(R)METHYL]-5-[(2(S)-TERTIARY-BUTYLAMINO- CARBONYL)-4-(N1-(2)-(N-METHYLPIPERAZINYL)- 3-CHLORO-PYRAZINYL-5-CARBONYL)- PIPERAZINO]-4(S)-HYDROXY-2(R)-PHENYLMETHYL- PENTANAMIDE | B | 2BPZ | 0.72 | |
3IN | N-[2(S)-CYCLOPENTYL-1(R)-HYDROXY- 3(R)METHYL]-5-[(2(S)-TERTIARY-BUTYLAMINO- CARBONYL)-4-(N1-(2)-(N-METHYLPIPERAZINYL)- 3-CHLORO-PYRAZINYL-5-CARBONYL)- PIPERAZINO]-4(S)-HYDROXY-2(R)-PHENYLMETHYL- PENTANAMIDE | B | 2BPY | 0.72 | |
3IN | N-[2(S)-CYCLOPENTYL-1(R)-HYDROXY- 3(R)METHYL]-5-[(2(S)-TERTIARY-BUTYLAMINO- CARBONYL)-4-(N1-(2)-(N-METHYLPIPERAZINYL)- 3-CHLORO-PYRAZINYL-5-CARBONYL)- PIPERAZINO]-4(S)-HYDROXY-2(R)-PHENYLMETHYL- PENTANAMIDE | B | 1C6X | 0.72 | |
APT | 2-AMINO-6-[(4-CARBOXY-PHENYLAMINO)- METHYL]-4-HYDROXY-PTERIDIN-1-IUM | A,B | 1QCJ | 0.76 | |
BMS | A,B | 1DKF | 0.71 | ||
NFL | 2-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}NICOTINIC ACID | A | 1TD7 | 0.78 | |
PVB | PURVALANOL | A | 1CKP | 0.72 | |
PVB | PURVALANOL | A,B | 1V0P | 0.72 | |
BTH | 4-OXO-3-{6-[4-(QUINOXALIN-2-YLAMINO)- BENZOYLAMINO]-2-THIOPHEN-2-YL-HEXANOYLAMINO}- PENTANOIC ACID | A | 1RWO | 0.71 | |
OQB | 4-OXO-3-[(6-{[4-(QUINOXALIN-2-YLAMINO)- BENZOYLAMINO]-METHYL}-PYRIDINE- 3-CARBONYL)-AMINO]-BUTYRIC ACID | A | 1RWW | 0.8 | |
L37 | A,B | 1DIG | 0.71 |